Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MERCK & CO INC via MERCK & CO, INC.
2008 · fourth_quarter · Q4
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029).
Support amendments to patent reform legislation concerning post-grant review authority, apportionment of damages, venue and inequitable conduct provisions (S. 1145, H.R. 1908)
Food and Drug Administration Amendments Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900) Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Merdicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900) Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation).
Support amendments to patent reform legislation concerning post-grant review authority, apportionment of damages, venue and inequitable conduct provisions (S. 1145, H.R. 1908)
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Merdicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
2008 · third_quarter · Q3
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2008 · second_quarter · Q2
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2008 · first_quarter · Q1
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2007 · year_end · YY
Support amendments to patent reform legislation concerning post-grant review authority, apportionment of damages, venue and inequitable conduct provisions (S. 1145, H.R. 1908)
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Merdicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900) Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation).
Educate members of Congress, USTR, Commerce, State on compulsory licenses in Thailand and Brazil (no specific legislation). Support intellectual property protections in trade negotiations. (Peru FTA, Panama FTA, Columbia FTA, Korea FTA).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 2008 Labor-HHS Appropriations bills) Support increased funding for FDA (FY 2008 Agriculture Appropriations bills).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2003 · year_end · YY
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2003 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
MERCK & CO INC via MERCK & CO, INC.
2002 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
MERCK & CO INC via MERCK & CO, INC.
2001 · mid_year · MM
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of
MERCK & CO INC via MERCK & CO, INC.
2000 · year_end · YY
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2000 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
1999 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)